It is a pharma public limited company based in Delhi, Delhi, India, established in 2013.
2013 | Delhi, Delhi, India | ActiveVenor Pharma Limited, a active public limited company, was established on 03 May 2013 in Delhi, Delhi, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U74900DL2013PLC251565. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 170 professional, Its leadership includes Shubham Verma (Director), Yogesh Kapoor (Director), Shivam Verma (Director). Past directors included Shubham Verma, Krishan Malhotra, Yogesh Kapoor. It holds ₹49.58 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A - 43, Ground Floor, G. T. Karnal Road Industrial Area, Delhi, Delhi, 110033.
U74900DL2013PLC251565
251565
03 May 2013
₹5.00 Cr
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Venor Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shubham Verma | Director | 31 Aug 2018 | Current |
| Yogesh Kapoor | Director | 08 Feb 2023 | Current |
| Shivam Verma | Director | 24 May 2023 | Current |
| Vishwas Verma | Director | 03 May 2013 | Current |
| Ritesh Khetarpal | Director | 01 Jun 2024 | Current |
| Savita Verma | Director | 03 May 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 31 Mar 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 06 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Venor Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.74% increase. The company also saw a substantial improvement in profitability, with a 66.15% increase in profit. The company's net worth Soared by an impressive increase of 125.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Venor Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹495,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2023 | Others | ₹15.00 Cr | Open |
| 20 Dec 2022 | Hdfc Bank Limited | ₹21.60 Cr | Open |
| 02 Aug 2022 | Others | ₹12.98 Cr | Open |
Explore comprehensive loan charge details -
Venor Pharma has a workforce of 170 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Venor Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venor Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Venor Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Ritesh Khetarpal was appointed as a Director was appointed as a Director on 01 Jun 2024 & has been associated with this company since 1 year 6 months . was documented.
A charge with Hdfc Bank Limited of Rs. 21.60 Cr registered on 20 Dec 2022 with Charge ID 100709156 was modified on 29 May 2024. was recorded as a recent event.
Venor Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Shivam Verma was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 2 years 6 months . was documented.
Progress on A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100715044 was registered on 11 May 2023. was documented.
The CIN of Venor Pharma Limited is U74900DL2013PLC251565.
Venor Pharma Limited is headquartered at A - 43, Ground Floor, G. T. Karnal Road Industrial Area, Delhi, Delhi, 110033.
Venor Pharma Limited was incorporated on 03 May 2013.
The current directors of Venor Pharma Limited are
The primary industry of Venor Pharma Limited is Hospital And Medical Care.
Venor Pharma Limited is unlisted.
The authorized capital of Venor Pharma Limited is ₹5.00 Cr, and the paid-up capital is ₹1.00 M.
The compliance status of Venor Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX